Cannabis or cannabidiol may improve or prevent symptoms of Restless Leg Syndrome in adults
This scoping review synthesized evidence from seven studies (case reports, cross-sectional surveys, post hoc analyses) out of 5,370 records identified up to April 30, 2025. The findings suggest cannabis or CBD may alleviate or prevent RLS symptoms, but the evidence is insufficient for clinical recommendations due to lack of high-quality RCTs.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Cannabis or cannabidiol may improve or prevent symptoms of Restless Leg Syndrome in adults The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 32/100 (low).
The Claim
Cannabis or cannabidiol may improve or prevent symptoms of Restless Leg Syndrome in adults
This conclusion is most relevant to: Adults with Restless Leg Syndrome.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effect of Cannabinoids use on Symptoms of Restless Leg Syndrome among Adults: A Scoping Review. (Annals of Indian Academy of Neurology, 2026) —
How It Works
The proposed biological pathway:
- ▸Cannabinoids interact with endocannabinoid system receptors
- ▸Modulation of dopaminergic and GABAergic pathways
- ▸Reduction of sensory and motor symptoms
- ▸Result: Alleviation or prevention of RLS symptoms
Who Might Benefit
Evidence fit by population:
- ▸Adults with Restless Leg Syndrome
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Only case reports, cross-sectional surveys, and post hoc analyses included; no RCTs
- ▸Small number of studies (n=7) and potential publication bias
- ▸Heterogeneity in cannabis forms, doses, and outcome measures
Frequently Asked Questions
Is cannabis effective for restless leg syndrome?▼
Current evidence suggests cannabis or CBD may improve or prevent RLS symptoms, but it is based on low-quality studies. High-quality RCTs are needed before clinical recommendations.
What type of studies were included in this review?▼
The review included seven studies: case reports, cross-sectional surveys, and post hoc analyses. No randomized controlled trials were found.
How many records were screened for this review?▼
A total of 5,370 records were identified from databases, and seven met inclusion criteria.
Should I use cannabis for RLS based on this evidence?▼
No, the evidence is insufficient to support clinical recommendations. Consult a healthcare provider for evidence-based treatments.
References
- 1.Saha S, Tripathi R, Saini LK, Kumar N, Gupta R. “Effect of Cannabinoids use on Symptoms of Restless Leg Syndrome among Adults: A Scoping Review..” Annals of Indian Academy of Neurology, 2026. PMID: 42617004 DOI: 10.4103/aian.aian_1168_25